We are live on ! Find out more
6CM

683 Capital Management Portfolio holdings

AUM $1.92B
1-Year Est. Return 85.52%
This Fund
S&P 500
This Quarter Est. Return
-14.38%
1 Year Est. Return
+85.52%
3 Year Est. Return
+282.16%
5 Year Est. Return
+254.87%
10 Year Est. Return
+3,288.81%
AUM
$1.42B
AUM Growth
-$452M
Cap. Flow
-$52.5M
Cap. Flow %
-3.71%
Top 10 Hldgs %
29.79%
Holding
375
New
15
Increased
44
Reduced
27
Closed
103

Sector Composition

Rank Sector Weight
1 Financials 33.53%
2 Healthcare 22.61%
3 Consumer Discretionary 10.28%
4 Industrials 7.33%
5 Communication Services 6.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HWKZ.WS
176
DELISTED
Hawks Acquisition Corp Public warrants, each whole public warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 per share
HWKZ.WS
$158K 0.01%
990,000
CLBTW
177
DELISTED
Cellebrite DI Ltd. Warrants
CLBTW
$134K 0.01%
172,950
-363,293
-68% -$331K
LILMW
178
DELISTED
Lilium N.V. Warrants
LILMW
$120K 0.01%
436,494
NESRW
179
DELISTED
National Energy Services Reunited Corp. Warrant
NESRW
$117K 0.01%
590,226
-641
-0.1% -$329
DHT icon
180
DHT Holdings
DHT
$2.99B
$116K 0.01%
19,000
-156,000
-89% -$916K
GTACW
181
DELISTED
Global Technology Acquisition Corp. I Warrant
GTACW
$115K 0.01%
767,500
BROGW
182
DELISTED
Brooge Holdings Limited Warrant expiring 12/20/2024
BROGW
$109K 0.01%
321,684
PCG icon
183
PG&E
PCG
$38.3B
$106K 0.01%
10,600
-119,400
-92% -$1.4M
LITTW
184
DELISTED
Logistics Innovation Technologies Corp. Warrant
LITTW
$106K 0.01%
666,665
OBIO icon
185
Orchestra BioMed
OBIO
$238M
$100K 0.01%
10,000
AEON icon
186
AEON Biopharma
AEON
$12.9M
$98K 0.01%
139
NOGNW
187
DELISTED
Nogin, Inc. Warrant
NOGNW
$96K 0.01%
400,000
OHAAW
188
DELISTED
OPY Acquisition Corp. I Warrant
OHAAW
$93K 0.01%
375,000
LMDX
189
DELISTED
LumiraDx Limited Common Shares
LMDX
$88K 0.01%
33,000
TCOA.WS
190
DELISTED
Zalatoris Acquisition Corp. Public warrants, each whole public warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 per share
TCOA.WS
$80K 0.01%
742,500
APMIW
191
DELISTED
AxonPrime Infrastructure Acquisition Corporation Warrants
APMIW
$76K 0.01%
333,333
+1
+0%
CLVR
192
DELISTED
Clever Leaves Holdings Inc. Common Shares
CLVR
$67K ﹤0.01%
+2,287
New +$91.3K
TIOAW
193
DELISTED
Tio Tech A Warrants
TIOAW
$67K ﹤0.01%
666,666
RKTA.WS
194
DELISTED
Rocket Internet Growth Opportunities Corp. Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share
RKTA.WS
$65K ﹤0.01%
375,000
KYCHR
195
DELISTED
Keyarch Acquisition Corporation Rights
KYCHR
$60K ﹤0.01%
350,000
+175,000
+100% +$28.4K
CLDI.WS
196
DELISTED
Calidi Biotherapeutics, Inc. Redeemable Warrants, each whole warrant exercisable for 1/10th of a share of Common Stock at an exercise price of $115.00
CLDI.WS
$54K ﹤0.01%
600,000
VMCAW
197
DELISTED
Valuence Merger Corp. I Warrant
VMCAW
$49K ﹤0.01%
+350,000
New +$58K
ARGUW
198
DELISTED
Argus Capital Corp. Warrant
ARGUW
$48K ﹤0.01%
250,000
CLNNW
199
DELISTED
Clene Inc Warrant
CLNNW
$46K ﹤0.01%
138,600
+3,600
+3% +$951
ENERR
200
DELISTED
Accretion Acquisition Corp Right
ENERR
$46K ﹤0.01%
375,000

Similar funds

683 Capital Management's Q2 2022 Portfolio in Review

As of Q2 2022, 683 Capital Management held 375 positions worth $1.42B, down 24% from $1.87B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

683 Capital Management withdrew a net $52.5M in Q2 2022, closing 103 positions and reducing 27 holdings. Its most notable exit was Herbalife, an estimated $43.7M position sold in full.

By sector, the portfolio is most concentrated in Financials at 34% of assets, up from 27% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, 683 Capital Management opened a new position in General Motors worth $38.3M.

  • 683 Capital Management's largest Q2 2022 buy was General Motors: 1,205,400 shares worth $38.3M.
  • 683 Capital Management added most to Carvana in Q2 2022, an estimated $46.6M increase.
  • 683 Capital Management's biggest Q2 2022 reduction was Lakefront Biotherapeutics American Depositary Shares, cutting an estimated $20.7M.
  • 683 Capital Management fully exited Herbalife in Q2 2022, selling an estimated $43.7M.
  • 683 Capital Management's ten largest holdings make up 30% of its $1.42B portfolio in Q2 2022.
  • 683 Capital Management opened 15 new positions and closed 103 in Q2 2022.
  • 683 Capital Management's portfolio value fell 24% quarter-over-quarter to $1.42B.

Based on 683 Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.